The Food and drug administration approved a greater 2 mg dose of once-weekly injectable semaglutide (Ozempic) for grownups with variety 2 diabetes centered on the stage III Sustain method, Novo Nordisk declared. The agent is currently readily available in .5 mg and 1 mg doses for this sign.
Most confront masks have minimal or negligible levels of per- and polyfluoroalkyl substances (PFAS) — endocrine-disrupting chemicals that can repel fluids — except for those people utilized by firefighters. (Environmental Science & Technologies Letters)
Early implementation of the Affected individual Protection and Affordable Care Act was connected with an advancement in significant amputation and hospitalization charges amid early-adoption states for Black, Hispanic, and other racial and ethnic minority older people with diabetic foot ulcerations. (JAMA Network Open)
Lannett Corporation declared that the very first individual was dosed in a pivotal clinical demo of biosimilar insulin glargine — a possibly interchangeable with Sanofi’s Lantus Solostar — with effects envisioned afterwards this 12 months.
Motivational interviewing flopped at bolstering excess weight reduction as portion of a behavioral excess weight administration program. “Presented the intensive schooling needed for its delivery, motivational interviewing may not be a worthwhile addition to behavioral body weight management courses,” scientists reported in Annals of Inner Medicine.
Executed by Purchaser Reports, an investigation of more than 100 food packaging goods from cafe and grocery chains located that many still have PFAS — even in packaging from sites saying to section out these hazardous endocrine disruptors.
The Endocrine Society announced it is launching a new open-entry journal centered on medical case experiences and scientific challenge solving: JCEM Case Experiences. It’s envisioned to becoming publishing later this calendar year.
A pre-peer reviewed study observed that sort 2 diabetic issues improved a person’s danger for establishing 57 other overall health disorders. (Insider)
The first client was enrolled in a period IIa trial of the investigational cure ACER-801 (osanetant) for moderate to severe vasomotor signs or symptoms associated with menopause, Acer Therapeutics announced.